IP Library Granted Patent US 10,517,759
Granted Patent B2
US 10,517,759 · App. 14/207,240 · Granted Dec 31, 2019

Glaucoma stent and methods thereof for glaucoma treatment

Inventors: Douglas Daniel Crimaldi (San Marcos, CA); Charles Raymond Kalina, Jr. (Irvine, CA)
Assignee: GLAUKOS CORPORATION
A61F9/00781
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,517,759
App. No.
14/207,240
Granted
Dec 31, 2019
Kind
B2
Abstract

The invention relates generally to medical devices and methods for reducing the intraocular pressure in an animal eye and, more particularly, to stent type devices for permitting aqueous outflow from the eye's anterior chamber and associated methods thereof for the treatment of glaucoma. Some aspects provide a self-trephining glaucoma stent and methods thereof which advantageously allow for a “one-step” procedure in which the incision and placement of the stent are accomplished by a single device and operation. This desirably allows for a faster, safer, and less expensive surgical procedure.

Claims (32)

1. A stent for reducing intraocular pressure by providing outflow of aqueous humor from an anterior chamber of a human eye, comprising:

a grommet, wherein the grommet comprises an inlet end, an outlet end, a seat member at the inlet end, a tapered base at the outlet end and a shank member connecting the seat member of the inlet end and the tapered base of the outlet end, the seat member having a diameter that is greater than a largest diameter of the tapered base and that is less than 1000 μm, wherein the grommet is configured to extend through the trabecular meshwork such that the inlet end resides in the anterior chamber, the outlet end resides in Schlemm's canal of the human eye, and the seat member is proximal of the trabecular meshwork; and

an inner lumen within the grommet, the lumen having an inlet port and an outlet port for providing a flow pathway through the grommet;

wherein the tapered base comprises at least one horizontal outlet in fluid connection with the inner lumen; and

wherein a diameter of at least a portion of the tapered base is greater than a largest diameter of the shank member.

2. The stent of claim 1 , wherein a depth of the shank member is about 100-500 μm.

3. The stent of claim 1 , wherein the seat member comprises a horizontal fluid conduit.

4. The stent of claim 3 , wherein the horizontal fluid conduit is a half-cylinder.

5. The stent of claim 3 , wherein the horizontal fluid conduit is a cylinder.

6. The stent of claim 1 , wherein the at least one horizontal outlet comprises a plurality of horizontal outlets in fluid connection with the inner lumen.

7. The stent of claim 1 , wherein the at least one horizontal outlet comprises four horizontal outlets that intersect perpendicular to the inner lumen.

8. The stent of claim 1 , wherein the seat member has a diameter greater than 100 μm.

9. The stent of claim 1 , wherein the seat member has a diameter greater than 500 μm.

10. A stent for reducing intraocular pressure by providing outflow of aqueous humor from an anterior chamber of a human eye, comprising:

a grommet, wherein the grommet comprises:

an inlet end,

an outlet end,

a seat member at the inlet end,

a tapered base at the outlet end, and

a shank member connecting the seat member of the inlet end and the tapered base of the outlet end,

wherein the seat member has a diameter that is greater than a largest diameter of the tapered base,

wherein a diameter of at least a portion of the tapered base is greater than a largest diameter of the shank member,

wherein the grommet is configured to extend through the trabecular meshwork such that, upon implantation, the inlet end resides in the anterior chamber, the outlet end resides in Schlemm's canal, and the seat member is proximal of the trabecular meshwork, and

an inner lumen, the inner lumen having an inlet port at the inlet end and an outlet port at the outlet end for providing a flow pathway through the grommet,

wherein the tapered base comprises a plurality of side-ports in fluid connection with the inner lumen.

11. The stent of claim 10 , wherein the seat member has a diameter in a range between 100 μm and 3000 μm.

12. The stent of claim 10 , wherein the seat member has a diameter in a range between 500 μm and 1500 μm.

13. The stent of claim 10 , wherein the plurality of side-ports comprises four side-ports.

14. The stent of claim 13 , wherein the side-ports are spaced apart equally about the tapered base.

15. The stent of claim 10 , wherein the seat member comprises at least one side port intersecting the inner lumen.

16. The stent of claim 10 , wherein the seat member comprises four side-ports intersecting the inner lumen.

17. The stent of claim 10 , wherein the seat member has a constant diameter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2014
From: CRIMALDI, DOUGLAS DANIEL; KALINA, CHARLES RAYMOND, JR.
To: GLAUKOS CORPORATION
Reel/Frame 033299/0608 →
Continuity (2)
Provisional Application 61794832 · Mar 15, 2013
Related Publication 20140276332A1 · Sep 18, 2014
Cited By (20)
US 1,137,672 US 12,186,237 US 12,201,555 US 12,201,557 US 12,208,034 US 12,226,308 US 12,239,806 US 12,279,822 US 12,343,288 US 12,376,989 US 12,414,798 US 12,419,783 US 12,427,057 US 12,478,503 US 12,478,504 US 12,514,750 US 12,575,972 US 12,599,497 US 12,667,486 US 12,702,294